Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antioxidant L-2264 ameliorates metabolic impairment in rats with insulin resistance

Sep. 14, 2005

Nonapprovable letter for lasofoxifene in prevention of osteoporosis

Sep. 14, 2005

New clinical evidence supports using oral insulin spray to improve glycemic control in diabetics

Sep. 14, 2005

New DPP-IV inhibitor highlighted as a therapeutic candidate for type 2 diabetes

Sep. 14, 2005

New insulin secretagogues for diabetes reported in recent Takeda patent

Sep. 14, 2005

Zonagen awards contracts for studies of Proellex and Androxal

Sep. 14, 2005

MicroIslet and Scripps Research Institute extend diabetes collaboration

Sep. 14, 2005

A-778193 reduced food intake and body weight via GHS-R antagonism

Sep. 14, 2005

SGL-0010: a novel orally active SGLT inhibitor for diabetes

Sep. 13, 2005

New 5-HT2C agonist shown to be a therapeutic candidate for obesity

Sep. 13, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...